Ruka hadi maudhui makuu
727 Finance
Kiswahili

OpenAI acquires drug R&D collaboration platform Orchestra Bio

PANews October 21 news, according to an official OpenAI announcement, OpenAI has acquired Orchestra Bio, a drug R&D collaboration platform. The platform helps biopharmaceutical teams coordinate complex drug development processes, allowing scientists and project leads to delegate the monitoring and tracking of research and trials to AI agents. OpenAI stated that it will integrate Orchestra's team and technology with Rosalind, its life sciences research AI model and tool, to help new therapies reach patients faster.

Habari zinazohusiana

  1. Financing Weekly | Kalshi completes $1 billion Series G funding, led by Sequoia Capital and Wellington Management.

    Kalshi completed a $1 billion Series G funding round, reaching a post-money valuation of $40 billion, nearly double its $22 billion valuation in May this year;...

  2. Jukwaa la biashara ya hisa mtandaoni StableStock limekamilisha awamu mpya ya ufadhili wa kimkakati kwa thamani ya dola milioni 75, likishirikisha Amber na wengine.

  3. RoboScience Machine Science inakamilisha mamia ya mamilioni ya yuan katika ufadhili wa Series A2.

  4. Lengo la OpenAI la kukusanya fedha limepunguzwa kwa dola bilioni 10: Je, "simulizi la kuteketeza fedha taslimu" la AI linapoteza nguvu?

  5. Rates Exchange, soko la kubadilishana riba na ua la hatari lililo kwenye mnyororo, limepokea uwekezaji kutoka Coinbase Ventures.